REFERENCE
Cowell W, Summerhayes M.Pharmacoeconomic evaluation of capecitabine (Xeloda) for gastric cancer in the United Kingdom. Value in Health 10: A330 (plus poster) abstr. PCN25, No. 6, Nov-Dec 2007
Rights and permissions
About this article
Cite this article
Capecitabine reduces cost burden of gastric cancer. Pharmacoecon. Outcomes News 540, 7 (2007). https://doi.org/10.2165/00151234-200705400-00011
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200705400-00011